Avenue Therapeutics News

Avenue Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Robert Davidow(2.9%)

May 2 16:06 ET

Avenue Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(8.0%)

Apr 17 16:11 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Apr 17 16:10 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Jan 3 00:00 ET

Avenue Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Jan 2 00:00 ET

Avenue Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Robert Davidow(9.89%)

Dec 13, 2023 16:03 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Davidow Robert L

Dec 13, 2023 16:02 ET

Avenue Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Robert Davidow(14.5%)

Nov 28, 2023 16:05 ET

Avenue Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Davidow Robert L

Nov 28, 2023 16:01 ET

Avenue Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fortress Biotech, Inc.(12.1%)

Sep 18, 2023 17:08 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROSENWALD LINDSAY A MD

Sep 12, 2023 09:03 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Sep 12, 2023 09:02 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Charles Faith L.

Jul 5, 2023 16:10 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jin David

Jul 5, 2023 16:09 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director ROSENWALD LINDSAY A MD

Jul 5, 2023 16:08 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KRANZLER JAY D

Jul 5, 2023 16:08 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Oltmans Curtis Gale

Jul 5, 2023 16:07 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Herskowitz Neil

Jul 5, 2023 16:07 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer MacLean Alexandra

Jul 3, 2023 13:05 ET

Avenue Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Fortress Biotech, Inc.

Apr 4, 2023 16:08 ET